Showing results (701-710 of 834) with videos related to

Sort By:
Pageof 84
Alzheimer'S Research & Therapy|August 8, 2019
Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's diseaseMichael F Egan, Yuki Mukai, Tiffini Voss, et al.
The American Journal of Psychiatry|May 3, 2003
A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's diseaseGeorge S Zubenko, Wendy N Zubenko, Susan McPherson, et al.
The Journal of Prevention of Alzheimer'S Disease|September 13, 2020
Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD)S Walter, T B Clanton, O G Langford, et al.
The American Journal of Pathology|June 8, 2014
Novel nuclear localization of fatty acid synthase correlates with prostate cancer aggressivenessAllison A Madigan, Kevin J Rycyna, Anil V Parwani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2021
A Phase Ib Open-Label, Multicenter Study of Inhaled DV281, a TLR9 Agonist, in Combination with Nivolumab in Patients with Advanced or Metastatic Non-small Cell Lung CancerEdward B Garon, Alexander I Spira, Melissa Johnson, et al.
The American Journal of Managed Care|April 30, 2014
Effective and efficient diagnosis of parkinsonism: the role of dopamine transporter SPECT imaging with ioflupane I-123 injection (DaTscan™)Jeffrey L Cummings, Michael J Fine, Igor D Grachev, et al.
Neuroimage|January 20, 2010
Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjectsLiana G Apostolova, Jonathan H Morra, Amity E Green, et al.
Risk Management and Healthcare Policy|July 16, 2021
Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates?Jeffrey C Cegan, Benjamin D Trump, Susan M Cibulsky, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 7, 2021
Intepirdine as adjunctive therapy to donepezil for mild-to-moderate Alzheimer's disease: A randomized, placebo-controlled, phase 3 clinical trial (MINDSET)Frederick M Lang, Yi Mo, Marwan Sabbagh, et al.
Neurology|May 9, 2001
Practice parameter: management of dementia (an evidence-based review) [RETIRED]. Report of the Quality Standards Subcommittee of the American Academy of NeurologyR S Doody, J C Stevens, C Beck, et al.
Pageof 84